Diabetes mellitus (DM) is one of the most common underlying diseases that may aggravates
COVID-19. In the present study, we explored islet function, the presence of SARS-CoV-2 and pathological changes in the pancreas of patients with
COVID-19. Oral
glucose tolerance tests (OGTTs) and the
C-peptide release test demonstrated a decrease in
glucose-stimulated
C-peptide secretory capacity and an increase in HbA1c levels in patients with
COVID-19. The prediabetic conditions appeared to be more significant in the severe group than in the moderate group. SARS-CoV-2 receptors (ACE2, CD147, TMPRSS2 and
neuropilin-1) were expressed in pancreatic tissue. In addition to SARS-CoV-2 virus spike
protein and virus RNA, coronavirus-like particles were present in the autophagolysosomes of pancreatic acinar cells of a patient with
COVID-19. Furthermore, the expression and distribution of various
proteins in pancreatic islets of patients with
COVID-19 were altered. These data suggest that SARS-CoV-2 in the pancreas may directly or indirectly impair islet function.